Abstract
A microwave assisted multi-component reaction involving 2-amino-1,3,4-thiadiazoles, aromatic aldehydes and thioglycolic acid as substrates, afforded a series of novel 2-(1,3,4-thiadiazolo)-3-aryl-4-thiazolidinones in good yields.
Keywords: 4-Thiazolidinones, microwave irradiation, synthesis.
Graphical Abstract
Letters in Organic Chemistry
Title:Microwave Assisted One-pot Three Component Synthesis of Novel 2-(5- Aryloxymethyl-1,3,4-thiadiazolo)-3-aryl-4-thiazolidinones
Volume: 12 Issue: 2
Author(s): Guoli Huang, Bo Liu, Mingyu Teng and Yegao Chen
Affiliation:
Keywords: 4-Thiazolidinones, microwave irradiation, synthesis.
Abstract: A microwave assisted multi-component reaction involving 2-amino-1,3,4-thiadiazoles, aromatic aldehydes and thioglycolic acid as substrates, afforded a series of novel 2-(1,3,4-thiadiazolo)-3-aryl-4-thiazolidinones in good yields.
Export Options
About this article
Cite this article as:
Huang Guoli, Liu Bo, Teng Mingyu and Chen Yegao, Microwave Assisted One-pot Three Component Synthesis of Novel 2-(5- Aryloxymethyl-1,3,4-thiadiazolo)-3-aryl-4-thiazolidinones, Letters in Organic Chemistry 2015; 12 (2) . https://dx.doi.org/10.2174/1570178612666141211224809
DOI https://dx.doi.org/10.2174/1570178612666141211224809 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Accomplices of NF-κB Lead to Radioresistance
Current Protein & Peptide Science Extracellular Vesicles as Novel Delivery Tools for Cancer Treatment
Current Cancer Drug Targets Flavonoids as Anticancer Agents: Structure-Activity Relationship Study
Current Medicinal Chemistry - Anti-Cancer Agents Structural Basis and Therapeutic Implication of the Interaction of CCN Proteins with Glycoconjugates
Current Pharmaceutical Design The Role of Antiangiogenetic Agents in the Treatment of Breast Cancer
Current Medicinal Chemistry Amino Acid Sequence Database Suitable for the Protein and Proteome Analysis
Current Proteomics Hematopoietic Stem Cells: Source Matters
Current Stem Cell Research & Therapy Antidotal Effects of Curcumin Against Agents-Induced Cardiovascular Toxicity
Cardiovascular & Hematological Disorders-Drug Targets Theranostic Systems and Strategies for Monitoring Nanomedicine-Mediated Drug Targeting
Current Pharmaceutical Biotechnology Celecoxib in Cancer Therapy and Prevention – Review
Current Drug Targets Targeting the Atypical Chemokine Receptor ACKR3/CXCR7: Phase 1 - Phage Display Peptide Identification and Characterization
Current Topics in Medicinal Chemistry Molecular Targeted Therapy in Prevalent Tumors: Learning from the Past and Future Perspectives
Current Clinical Pharmacology Overview of Prostate Biomarkers as Potential Targets for Immunotherapy
Current Cancer Therapy Reviews Synthesis, Characterization by Means of IR, 1H, 13C - NMR and Biological Investigations on New Diorganotin Carboxylic Acid Derivatives
Letters in Drug Design & Discovery Three Amino Acid Derivatives of Valproic Acid: Design, Synthesis, Theoretical and Experimental Evaluation as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Genetic and Epigenetic Signatures in Human Hepatocellular Carcinoma:A Systematic Review
Current Genomics Metabolism of the Endocannabinoids Anandamide and 2-Arachidonoyl Glycerol, A Review, with Emphasis on the Pharmacology of Fatty Acid Amide Hydrolase, A Possible Target for the Treatment of Neurodegenerative Diseases and Pain
Current Medicinal Chemistry - Central Nervous System Agents Microenvironmental Interactions in Chronic Lymphocytic Leukemia: Hints for Pathogenesis and Identification of Targets for Rational Therapy
Current Pharmaceutical Design A Combined Approach with Rituximab Plus Anti-TRAIL-R Agonistic Antibodies for the Treatment of Haematological Malignancies
Current Pharmaceutical Design Overcoming the Hurdles of Tumor Immunity by Targeting Regulatory Pathways in Innate and Adaptive Immune Cells
Current Pharmaceutical Design